Works matching IS 10837159 AND DT 2012 AND VI 17 AND IP 1
Results: 24
Bevacizumab in Clinical Practice: Prescribing Appropriateness Relative to National Indications and Safety.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Editor's Note... Clinical Trial Reports: A New Section.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
HHV-8-Associated Multicentric Castleman's Disease in HIV-Negative Patient: A Novel Therapy for an Orphan Disease.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Bevacizumab in Clinical Practice: Prescribing Appropriateness Relative to National Indications and Safety.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 117, doi. 10.1634/theoncologist.2011-0184
- By:
- Publication type:
- Article
Shared Decision Making in Oncology Practice: What Do Oncologists Need to Know?
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 91, doi. 10.1634/theoncologist.2011-0261
- By:
- Publication type:
- Article
Editor's Note... Clinical Trial Reports: A New Section.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Neoplasms Associated with Germline and Somatic NF1 Gene Mutations.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 101, doi. 10.1634/theoncologist.2010-0181
- By:
- Publication type:
- Article
Maintenance Therapy for First-Line Metastatic Colorectal Cancer: Activity and Sustainability.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Vaccination of Oncology Patients: An Effective Tool and an Opportunity Not to Be Missed.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 80, doi. 10.1634/theoncologist.2011-0177
- By:
- Publication type:
- Article
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 72, doi. 10.1634/theoncologist.2011-0386
- By:
- Publication type:
- Article
Results of the GYNECO 02 Study, an FNCLCC Phase III Trial Comparing Hysterectomy with No Hysterectomy in Patients with a (Clinical and Radiological) Complete Response After Chemoradiation Therapy for Stage IB2 or II Cervical Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 64, doi. 10.1634/theoncologist.2011-0276
- By:
- Publication type:
- Article
Age-Specific Nonpersistence of Endocrine Therapy in Postmenopausal Patients Diagnosed with Hormone Receptor-Positive Breast Cancer: A TEAM Study Analysis.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 55, doi. 10.1634/theoncologist.2011-0037
- By:
- Publication type:
- Article
Cancer-Associated Isocitrate Dehydrogenase Mutations.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Sarcomatoid Renal Cell Carcinoma: A Comprehensive Review of the Biology and Current Treatment Strategies.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 46, doi. 10.1634/theoncologist.2011-0227
- By:
- Publication type:
- Article
Vitamin D and Breast Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 36, doi. 10.1634/theoncologist.2011-0278
- By:
- Publication type:
- Article
Reflections.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 1, doi. 10.1634/theoncologist.2012-1001
- Publication type:
- Article
Is There Such a Thing as a Cancer Treatment That Isn't Worth Its Cost?
- Published in:
- 2012
- By:
- Publication type:
- Opinion
Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2 Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 26, doi. 10.1634/theoncologist.2011-0212
- By:
- Publication type:
- Article
First-Line XELOX Plus Bevacizumab Followed by XELOX Plus Bevacizumab or Single-Agent Bevacizumab as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: The Phase III MACRO TTD Study.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 15, doi. 10.1634/theoncologist.2011-0249
- By:
- Publication type:
- Article
Panitumumab in Patients with KRAS Wild-Type Colorectal Cancer after Progression on Cetuximab.
- Published in:
- 2012
- By:
- Publication type:
- Abstract
Oral Adverse Events Associated with Tyrosine Kinase and Mammalian Target of Rapamycin Inhibitors in Renal Cell Carcinoma: A Structured Literature Review.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 135, doi. 10.1634/theoncologist.2011-0111
- By:
- Publication type:
- Article
Phase II Trial of Erlotinib and Docetaxel in Advanced and Refractory Hepatocellular and Biliary Cancers: Hoosier Oncology Group GI06-101.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 13, doi. 10.1634/theoncologist.2011-0253
- By:
- Publication type:
- Article
Immunogenicity of an Inactivated Monovalent 2009 Influenza A (H1N1) Vaccine in Patients Who Have Cancer.
- Published in:
- Oncologist, 2012, v. 17, n. 1, p. 125
- By:
- Publication type:
- Article